Pall G - Search Results

1

High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer.

Salcher S, Sturm G, Horvath L, Untergasser G, Kuempers C, Fotakis G, Panizzolo E, Martowicz A, Trebo M, Pall G, Gamerith G, Sykora M, Augustin F, Schmitz K, Finotello F, Rieder D, Perner S, Sopper S, Wolf D, Pircher A, Trajanoski Z. Salcher S, et al. Among authors: pall g. Cancer Cell. 2022 Dec 12;40(12):1503-1520.e8. doi: 10.1016/j.ccell.2022.10.008. Epub 2022 Nov 10. Cancer Cell. 2022. PMID: 36368318 Free PMC article.

2

Basic clinical parameters predict gefitinib efficacy in non-small cell lung cancer.

Pircher A, Ulsperger E, Hack R, Jamnig H, Pall G, Zelger B, Sterlacci W, Hilbe W, Fiegl M. Pircher A, et al. Among authors: pall g. Anticancer Res. 2011 Sep;31(9):2949-55. Anticancer Res. 2011. PMID: 21868543

3

Small steps of improvement in small-cell lung cancer (SCLC) within two decades: a comprehensive analysis of 484 patients.

Fiegl M, Pircher A, Waldthaler C, Gamerith G, Kocher F, Pall G, Nevinny M, Schmid T, Sterlacci W, Jamnig H, Zangerl G, Zabernigg A, Oberaigner W, Hilbe W. Fiegl M, et al. Among authors: pall g. Lung Cancer. 2014 May;84(2):168-74. doi: 10.1016/j.lungcan.2014.02.005. Epub 2014 Feb 17. Lung Cancer. 2014. PMID: 24646832

4

Neoadjuvant chemo-immunotherapy modifies CD4(+)CD25(+) regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patients.

Pircher A, Gamerith G, Amann A, Reinold S, Popper H, Gächter A, Pall G, Wöll E, Jamnig H, Gastl G, Wolf AM, Hilbe W, Wolf D. Pircher A, et al. Among authors: pall g. Lung Cancer. 2014 Jul;85(1):81-7. doi: 10.1016/j.lungcan.2014.04.001. Epub 2014 Apr 13. Lung Cancer. 2014. PMID: 24780112

5

Systematic review: Soluble immunological biomarkers in advanced non-small-cell lung cancer (NSCLC).

Mildner F, Sopper S, Amann A, Pircher A, Pall G, Köck S, Naismith E, Wolf D, Gamerith G. Mildner F, et al. Among authors: pall g. Crit Rev Oncol Hematol. 2020 Sep;153:102948. doi: 10.1016/j.critrevonc.2020.102948. Epub 2020 May 5. Crit Rev Oncol Hematol. 2020. PMID: 32645684 Free article. Review.

6

Molecular Characteristics of Radon Associated Lung Cancer Highlights MET Alterations.

Gamerith G, Kloppenburg M, Mildner F, Amann A, Merkelbach-Bruse S, Heydt C, Siemanowski J, Buettner R, Fiegl M, Manzl C, Pall G. Gamerith G, et al. Among authors: pall g. Cancers (Basel). 2022 Oct 19;14(20):5113. doi: 10.3390/cancers14205113. Cancers (Basel). 2022. PMID: 36291897 Free PMC article.

7

Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck Cancer.

Wagner SM, Magnes T, Melchardt T, Kiem D, Weiss L, Neureiter D, Wagner C, Aretin MB, Nemec S, Gamerith G, Pall G, Greil R, Fuereder T. Wagner SM, et al. Among authors: pall g. Anticancer Res. 2023 Mar;43(3):1273-1282. doi: 10.21873/anticanres.16274. Anticancer Res. 2023. PMID: 36854497

8

Multicenter Phase II Study Evaluating Two Cycles of Docetaxel, Cisplatin and Cetuximab as Induction Regimen Prior to Surgery in Chemotherapy-Naive Patients with NSCLC Stage IB-IIIA (INN06-Study).

Hilbe W, Pall G, Kocher F, Pircher A, Zabernigg A, Schmid T, Schumacher M, Jamnig H, Fiegl M, Gächter A, Freund M, Kendler D, Manzl C, Zelger B, Popper H, Wöll E. Hilbe W, et al. Among authors: pall g. PLoS One. 2015 May 28;10(5):e0125364. doi: 10.1371/journal.pone.0125364. eCollection 2015. PLoS One. 2015. PMID: 26020783 Free PMC article. Clinical Trial.

9

Clinical decision-making and health-related quality of life during first-line and maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC): findings from a real-world setting.

Sztankay M, Giesinger JM, Zabernigg A, Krempler E, Pall G, Hilbe W, Burghuber O, Hochmair M, Rumpold G, Doering S, Holzner B. Sztankay M, et al. Among authors: pall g. BMC Cancer. 2017 Aug 23;17(1):565. doi: 10.1186/s12885-017-3543-7. BMC Cancer. 2017. PMID: 28835219 Free PMC article.

10

Cerebrospinal Fluid Drug Concentrations and Clinical Outcome of Patients with Neoplastic Meningitis Treated with Liposomal Cytarabine.

Bohn JP, Reinstadler V, Pall G, Stockhammer G, Steurer M, Oberacher H, Wolf D. Bohn JP, et al. Among authors: pall g. Eur J Drug Metab Pharmacokinet. 2019 Dec;44(6):845-851. doi: 10.1007/s13318-019-00572-w. Eur J Drug Metab Pharmacokinet. 2019. PMID: 31435852 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page